Autophagy in drug resistance of the multiple myeloma cell line RPMI8226 to doxorubicin

Genet Mol Res. 2015 May 25;14(2):5621-9. doi: 10.4238/2015.May.25.14.

Abstract

We investigated the effect of autophagy on drug resistance of multiple myeloma (MM) to doxorubicin (DOX). A DOX-resistant MM cell line (RPMI8226/DOX) was developed by progressively increasing the DOX concentration gradient. The drug resistance index was determined using the MTT method. Transmission electron microscopy, anti-light chain 3-fluorescein isothiocyanate immunofluorescence, and Western blotting were used to detect autophagy of MM cells. Flow cytometry was applied to detect changes in apoptosis of RPMI8226/DOX cells (stained with annexin-V/propidium iodide) caused by inhibition by hydroxychloroquine and 3-methyladenine on autophagy. The drug resistance index of RPMI8226/DOX to DOX was 10.8, and autophagy/lysosomal was clearly observed in RPMI8226/DOX cells under transmission electron microscopy, while immunofluorescence showed granular immunofluorescence in cells. Western blot analysis showed that light chain 3-II protein expression level was higher in RPMI8226/DOX cells than in RPMI8226/S cells. The apoptosis test showed that hydroxychloroquine or 3-methyladenine partially reversed the drug resistance of RPMI8226/DOX cells by inhibiting autophagy. Activation of autophagy in MM cells may explain the drug resistance of myeloma.

MeSH terms

  • Apoptosis / drug effects
  • Autophagy / genetics*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Doxorubicin / administration & dosage*
  • Drug Resistance, Neoplasm / genetics*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / genetics
  • Multiple Myeloma / pathology
  • RNA, Small Interfering
  • Signal Transduction / drug effects

Substances

  • RNA, Small Interfering
  • Doxorubicin